EDWARDSVILLE, IL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Flint Cooper is proud to announce that Alex Parker has been appointed to the Leadership Development Committee (LDC) for the Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation, MDL No. 3092. This appointment by the United States District Court for the Northern District of Ohio, Eastern Division, underscores Parker’s commitment to mass tort litigation and his potential as a future leader in this field. “Alex Parker’s appointment to the Lead ...